• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Cartesian Growth Corporation II

    5/9/25 4:15:37 PM ET
    $RENE
    Blank Checks
    Finance
    Get the next $RENE alert in real time by email
    false 0001889112 00-0000000 0001889112 2025-05-06 2025-05-06 0001889112 RENEU:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneThirdOfOneWarrantMember 2025-05-06 2025-05-06 0001889112 us-gaap:CommonClassAMember 2025-05-06 2025-05-06 0001889112 us-gaap:WarrantMember 2025-05-06 2025-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): May 6, 2025

     

     

    Cartesian Growth Corporation II

    (Exact name of registrant as specified in its charter)

     

     

    Cayman Islands 001-41378 N/A
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (I.R.S. Employer
    Identification No.)

     

    505 Fifth Avenue, 15th Floor

    New York, New York

    10017
    (Address of principal executive offices) (Zip Code)

     

    (212) 461-6363

    (Registrant’s telephone number, including area code)

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange
    on which registered
    Units, each consisting of one class A ordinary share and one-third of one Warrant   RENEU   The Nasdaq Stock Market LLC
    Class A ordinary shares, par value $0.0001 per share   RENE   The Nasdaq Stock Market LLC
    Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   RENEW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 3.01          Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    On May 6, 2025, Cartesian Growth Corporation II (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that, pursuant to Nasdaq Listing Rule IM-5101-2 (“Rule IM-5101-2”), the staff of Nasdaq (“Staff”) had determined that (i) the Company’s securities will be delisted from Nasdaq, (ii) trading of the Company’s Class A common stock, warrants, and units will be suspended at the opening of business on May 13, 2025 and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement. Since the Company failed to complete its initial business combination by May 5, 2025, the Staff concluded that the Company did not comply with Rule IM-5101-2 and that the Company’s securities are subject to delisting.

     

    The Company will not appeal Nasdaq’s determination to delist the Company’s securities and accordingly, the Company’s securities will be suspended from trading on Nasdaq at the opening of business on May 13, 2025. The Company expects its securities to be quoted on the over-the-counter market following delisting from Nasdaq. The Company is working diligently to complete an initial business combination as soon as practicable.

     

    The Company will remain a reporting entity under the Securities Exchange Act of 1934, as amended, with respect to continued disclosure of financial and operational information. 

     

    Cautionary Note Regarding Forward Looking Statements:

     

    This Current Report on Form 8-K contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Private Securities Litigation Reform Act of 1995, including statements regarding the expected quotation of the Company’s securities on the over-the-counter market and its ability to complete an initial business combination. These statements reflect the beliefs and assumptions of the Company’s management as of the date hereof. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would,” variations of such words, and similar expressions are intended to identify forward-looking statements. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. The Company’s actual results could differ materially and adversely from those expressed in or contemplated by the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date on which they are made. The Company undertakes no obligation to update or revise any forward-looking statements for any reason.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    CARTESIAN GROWTH CORPORATION II  
         
    By: /s/ Peter Yu  
    Name: Peter Yu  
    Title: Chief Executive Officer  
         

    Date: May 9, 2025

     

     

    Get the next $RENE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RENE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RENE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cartesian Growth Corporation II

      SC 13G/A - Cartesian Growth Corp II (0001889112) (Subject)

      11/15/24 9:26:46 AM ET
      $RENE
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Cartesian Growth Corporation II

      SC 13G - Cartesian Growth Corp II (0001889112) (Subject)

      11/14/24 6:04:33 AM ET
      $RENE
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Cartesian Growth Corporation II

      SC 13G/A - Cartesian Growth Corp II (0001889112) (Subject)

      10/7/24 4:48:25 PM ET
      $RENE
      Blank Checks
      Finance

    $RENE
    SEC Filings

    See more
    • Cartesian Growth Corporation II filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Cartesian Growth Corp II (0001889112) (Filer)

      5/28/25 6:23:02 AM ET
      $RENE
      Blank Checks
      Finance
    • Cartesian Growth Corporation II filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - Cartesian Growth Corp II (0001889112) (Filer)

      5/19/25 5:00:55 PM ET
      $RENE
      Blank Checks
      Finance
    • SEC Form 10-Q filed by Cartesian Growth Corporation II

      10-Q - Cartesian Growth Corp II (0001889112) (Filer)

      5/15/25 5:31:04 PM ET
      $RENE
      Blank Checks
      Finance

    $RENE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Cgc Ii Sponsor Llc converted options into 5,749,998 units of Class A ordinary shares (SEC Form 4)

      4 - Cartesian Growth Corp II (0001889112) (Issuer)

      10/3/23 7:08:39 PM ET
      $RENE
      Blank Checks
      Finance